TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
RB Akut&Dykmedicin AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
63
|
88 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
27
|
-13 | |
| EBITDA |
31
|
-6 | |
| Total assets |
158
|
186 | |
| Current assets |
23
|
47 | |
| Current liabilities |
9
|
31 | |
| Equity capital |
130
|
136 | |
| - share capital |
5
|
4 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
82.3%
|
73.1% | |
| Turnover per employee |
63
|
88 | |
| Profit as a percentage of turnover |
42.9%
|
-14.8% | |
| Return on assets (ROA) |
17.1%
|
-7.0% | |
| Current ratio |
255.6%
|
151.6% | |
| Return on equity (ROE) |
20.8%
|
-9.6% | |
| Change turnover |
-26
|
-23 | |
| Change turnover % |
-22%
|
-29%
|
-21% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.